Skip to product information
Selected Variant Image
She-Lajit Honey Sticks
Subscription /
30 days
Regular price $48
Regular price $60 Sale price $48
Selected Variant Image
She-Lajit Honey Sticks
Subscription /
30 days
Regular price $48
Regular price $60 Sale price $48

THE AHA, DEEPER

Twelve symptoms. One signal. Why every single-pathway supplement only works halfway.

You did not arrive here without trying things. You tried Bonafide. Maybe Womaness. The shatavari capsule from Amazon at $20. The melatonin. The magnesium. Some of them helped a little. None of them did what you wanted. There is a structural reason for that, and it has nothing to do with whether you stuck with them long enough. Single-pathway designs target one device on a network that has twelve devices misfiring. They fail not because they are weak but because they were never built for the shape of the problem.

Estrogen is the WiFi of your body. Progesterone — and the calming brain chemical your body makes from it — is the bedtime side of the same network. Estrogen receptors live on the cells inside your brain that govern mood, focus, memory, sleep, body temperature, and pleasure. They live in your joints, your skin, your gut, your blood vessels, the lining of your bladder. When the cyclical signal goes erratic and then quiet, twelve systems start misfiring at the same time. The 4-Pathway Bloom Method addresses the system level: shatavari at the receptor, saffron at the brain branch, shilajit at the amplifying loops — three molecular pathways the rest of the category covers one or two of, never all three.

The fourth pathway is the unlock that makes the first three matter. Capsule shatavari, capsule saffron, capsule shilajit are all real ingredients at real doses — and the liver destroys 70–90% of each one before it reaches your bloodstream. The same compounds in a honey stick are absorbed across the oral mucosa under your tongue. They drain into the internal jugular veins and enter systemic circulation directly. First-pass liver metabolism is bypassed. The arithmetic on the other end is 3–10× more of each compound arriving intact. This is not a marketing line. It is a pharmacokinetic principle that explains why women who tried capsule versions of these same ingredients reported it kind of worked. Most of the dose was destroyed before it ever reached the receptors.

One stick. Four signals. Twelve rooms, supported at once.

THE ARCHITECTURE

The diagram is the same as the homepage. The table is new.

The diagram is the same as the homepage. The table is new.

Inspect for eight seconds. Every pathway resolves: named compound, named dose, named effect, named trial.

Shatavari · 80 mg standardizedAsparagus racemosus, shatavarin saponins with SERM activity at ERα/ERβ + HPA-axis modulation → vasomotor, sleep, mood, libido. Pingali Cureus 2024, RCT n=70, PMID 38725785 (trial used a higher oral dose; we deliver 80 mg sublingually).

Saffron · 2 mg standardizedCrocus sativus, crocin + safranal at TPH2, MAO-A, dopamine, GABA → mood, anhedonia, central desire. Hausenblas J Integrative Med 2013 · Kashani Avicenna J Phytomed 2022. Note: published trials used 30 mg/day; per-stick dose here is 2 mg. We cite the research to show the compound is studied — not to claim equivalent effect at lower dose.

Shilajit · 300 mg purified — fulvic acid + DBPs + 80+ ionic trace minerals at mitochondria, NF-κB, BMD. Pingali Phytomedicine 2022 (RCT n=60, 48 wks) · Mosavi 2023 (FSFI at 90 days).

Sublingual delivery · 8 g honey vehicle — oral mucosa absorption → internal jugular veins → systemic circulation. Bypasses first-pass hepatic metabolism. 3–10× higher systemic exposure. StatPearls NBK557852.

See every citation on Our Science →

What to expect, week by week.

You've been told to wait by every doctor who dismissed you. Here is what the cited trials measured and when.

W 1–2

Week 1–2

The first thing changing is upstream of anything you'd notice. The receptors are starting to respond. The brain branch — saffron's effect on serotonin and GABA tone — is the part that moves earliest in the trials, but at the perceptible level, this is the "my sleep got a little quieter at 3 a.m." phase. Don't quit because nothing has happened. The chemistry is doing exactly what it does at week 2.

W 3–4

Week 3–4

This is where most women in the Pingali 2024 Cureus RCT first reported measurable change on mood, anxiety, and sleep onset. If you're keeping the weekly tracker we send you, this is the week to compare back to your Day 1 baseline. You will see things on the page you would not have noticed in real time.

W 6–8

Week 6–8

The Pingali 2022 Phytomedicine trial's inflection on bone density and the Kashani 2022 trial's FSFI improvement both cluster here. Hot flashes typically begin to shift in this window. So does desire — the actual appetite, not the mechanics — because the central dopaminergic tone has had enough time to rebuild.

W 12+

Week 12+

The Hausenblas 2013 saffron-mood meta-analysis endpoint, the Pingali 2024 Cureus full effect window, and most of our customer cohort's "I caught myself feeling like me again" week all sit here. This is the bar. If you are not feeling change by week 12, the next section tells you exactly what to do.

Late Bloomer note (postmenopausal): If you are ten or more years past your last period, the inflection may sit later — Pingali 2022 Phytomedicine ran 48 weeks specifically in this cohort. Patience is not weakness; it is what the trial measured.

THE FOURTH PATHWAY

Why under the tongue beats inside a capsule.

Sublingual honey stick under tongue
Capsule vs sublingual route comparison

Left: capsule route — gut → liver → 70–90% destruction → ~10–30% reaches circulation. Right: sublingual route — oral mucosa → internal jugular veins → systemic circulation. No first-pass loss.

Capsule supplements are designed to be swallowed. They travel from your stomach through your small intestine and into the portal vein, which delivers everything you absorbed directly to your liver before any of it reaches the rest of your body. The liver's job there is to metabolize what arrives — to break compounds down, conjugate them, neutralize what looks foreign. For most botanicals, that means 70–90% of the dose is destroyed in the first hepatic pass. The remaining 10–30% reaches systemic circulation. This is why the shatavari capsule and the saffron capsule and the shilajit capsule on Amazon at $20 produce the partial effects you have read about in reviews — not because the ingredients are weak. Because most of the ingredient never made it past the front door.

Sublingual delivery is a different route in. Under your tongue is a thin, highly vascular mucous membrane. Compounds that dissolve into it are absorbed by the underlying capillary bed and drained directly into the internal jugular veins — which empty into the superior vena cava and into systemic circulation. The hepatic portal system is bypassed entirely. The first-pass hepatic metabolism that destroys most of a swallowed dose does not happen. This is not a hack. It is the route nitroglycerin uses to abort an angina attack within ninety seconds. It is the route the pharmacology literature describes as the standard delivery channel for compounds with extensive hepatic clearance.

In practice, the same compounds delivered sublingually arrive at receptors at 3–10× the systemic concentration they would reach as capsules. This is why She-Lajit Honey Sticks use lower per-stick milligram numbers than the capsule competitors. The dose on the label is what your bloodstream actually sees, not what the bottle contained on the way in.

3–10× more arrives intact.

Sublingual bypasses first-pass hepatic metabolism.
StatPearls NBK557852.

THE INGREDIENTS, DEEP

Four ingredients. Three actives and one delivery vehicle.

Each ingredient named, dosed, sourced, cited, and tested. Saffron is delivered sublingually at 2 mg; the published saffron trials used 30 mg oral. We cite the research to show the compound is studied; we do not claim equivalent effect at the lower dose.

Shatavari

INGREDIENT 1 OF 4 · RECEPTOR-LEVEL SIGNAL

Shatavari · Asparagus racemosus

80 mg standardized (≥40% saponins)

Source: India — Western Ghats, supplier-verified at lot levelHeritage: Charaka Samhita ~100 BCE–200 CE · Sushruta Samhita ~600 BCE — foremost female Rasayana

Shatavari supports the upstream signal at the receptor level — SERM-like activity at ERα/ERβ plus HPA-axis modulation. Pingali 2024 (Cureus, PMID 38725785) ran a double-blind, multicenter RCT on 70 peri- and postmenopausal women on standardized shatavari root extract and showed significant Utian Quality of Life gains by day 60. The trial used a higher oral dose; our 80 mg is standardized and delivered sublingually, so we cite the trial for the effect in menopausal women, not for an identical dose.

Pingali Cureus 2024, n=70 RCT →✓ HPLC shatavarin saponin assay · USP <232> heavy metals · USP <2021> microbial limits
Saffron

INGREDIENT 2 OF 4 · BRAIN-SIDE NEUROCHEMISTRY

Saffron · Crocus sativus

2 mg standardized (≥2% safranal)

Source: Greece (single-source farm) or Iran (lot-dependent)Heritage: Edwin Smith Papyrus ~1600 BCE · Persian and Mughal medicine for mood and desire for 3,000+ years

Saffron works on the brain side — crocin and safranal at TPH2, MAO-A, dopamine, and GABA. The clinical literature (Hausenblas 2013 meta-analysis; Kashani 2022) studies saffron at roughly 30 mg oral; we cite it to establish the compound's neuropharmacology, not to claim the same effect at our 2 mg sublingual dose. The dose-matched, RCT-backed clinical weight in this formula rides on shatavari and shilajit.

Saffron neuropharmacology — Hausenblas 2013, Kashani 2022 (30 mg oral) →✓ HPLC crocin + safranal · ISO 3632 saffron grade · USP <232> heavy metals
Shilajit

INGREDIENT 3 OF 4 · AMPLIFYING LOOPS

Shilajit · Asphaltum punjabianum

300 mg purified (≥50% fulvic acid)

Source: India / Tibet — high-altitude, PrimaVie® or equivalentHeritage: Charaka Samhita universal Rasayana · Tibetan Sowa Rigpa tradition for endurance and bone strength

Shilajit works the amplifying loops — mitochondria, NF-κB, bone mineral density. Pingali 2022 Phytomedicine — RCT n=60 postmenopausal women, 48 weeks, dose-dependent BMD preservation at lumbar spine and femoral neck. Mosavi 2023 — RCT FSFI improvement at 90 days in reproductive-age women (mechanistically relevant for post-oophorectomy cohorts).

Pingali Phytomedicine 2022, n=60 RCT 48 wks · Mosavi 2023 RCT →✓ Fulvic acid % by titration · DBP confirmation by HPLC · USP <232> heavy metals (critical for shilajit)
Honey vehicle

INGREDIENT 4 OF 4 · THE DELIVERY VEHICLE (NOT A RECEPTOR)

Honey vehicle · Apis mellifera

8 g sublingual stick

Source: US apiaries (Florida) — lot-traceableHeritage: Kahun Gynaecological Papyrus ~1800 BCE — oldest surviving women's-medicine text

The vehicle preceded the science by ~3,800 years. The Kahun Gynaecological Papyrus describes honey-based vehicles for botanical delivery in women's medicine. Sublingual oral mucosal absorption routes the actives through the internal jugular veins directly into systemic circulation, bypassing first-pass hepatic metabolism — 3–10× more of the three molecular pathways arrives in your bloodstream intact than the same compounds in a capsule.

The route, not a receptor. The delivery is the unlock.

StatPearls NBK557852 — sublingual route bioavailability →✓ US apiary lot-traceable · independent moisture + pesticide screen · USP food-grade

HRT

Some women take HRT. Some can't. Some won't. We made this for all three.

Path 1

With HRT

You are on estradiol, progesterone, or both. The patch is working. The hot flashes are mostly handled. The mood floor lifted. There are still gaps — the brain fog, the energy, the libido that did not come all the way back, the joint pain HRT does not touch.

The 4-Pathway Bloom Method covers receptor-level signal support that overlaps with what your HRT is doing — and the brain-side and amplifying-loop pathways that HRT does not address directly. It runs alongside.

See: Can I take this with my HRT? — in the FAQ below.

Path 2

Can't HRT

Breast cancer history. Tamoxifen. Endometrial cancer. Active hormone-sensitive disease. Tested BRCA positive and made the choice. Your oncologist has told you HRT is not an option for you — and many of the menopause 'alternatives' on the market are phytoestrogens at functional dose, which carries some of the same caution.

She-Lajit Honey Sticks are non-hormonal. The shatavari fraction has SERM-like activity at the receptor level but is not estradiol and not bioequivalent — send the formulation to your oncologist before starting. We built the After Cancer page below for this exact conversation.

Path 3

Won't HRT

You read the WHI history. You read what came after. You looked at your own risk profile and the available data and made an informed decision against HRT — or you took it once and stopped, or your mother stopped and you watched it. We are not here to argue you back into the chair.

The 4-Pathway Bloom Method is the OTC mechanism-led stack built for the woman who wants the work done at the network level without taking the bioequivalent hormone.

See: Won't HRT — the comparison page.

COMPATIBILITY

Can I take She-Lajit Honey Sticks with…

HRT (estradiol patch, oral progesterone, testosterone cream)Compatible

She-Lajit Honey Sticks are non-hormonal. The receptor-level activity of the shatavari fraction overlaps mechanically with what HRT supplies but does not stack to a supraphysiologic dose at any single receptor at the standardized 80 mg per stick. Most of our with-HRT customers run the protocols together. No dose adjustment required for either.

SSRIs / SNRIs (sertraline, escitalopram, venlafaxine, duloxetine)Compatible with awareness

Saffron has documented serotonergic activity — meta-analyzed at fluoxetine-equivalence at 30 mg oral. At our 2 mg sublingual dose, the systemic serotonergic load is meaningfully lower. We have not seen reports of serotonin syndrome at this dose. Mention saffron to your prescriber if you are on an SSRI or SNRI, and start with a one-stick-a-day cadence.

Anticoagulants (warfarin, apixaban, rivaroxaban, dabigatran)Consult your prescribing physician

Shatavari and shilajit have limited interaction data with the DOACs and with warfarin specifically. We do not have the studies to support a categorical compatibility claim. Bring the formulation to your hematologist or your prescribing physician and let them decide.

Breast cancer history · Tamoxifen · Aromatase inhibitorsWith care — consult your oncologist

Shatavari's SERM-like activity at ERα/ERβ is the mechanism your oncologist will want to evaluate. The 80 mg standardized dose is below the threshold most phytoestrogen literature flags, but this is a decision your oncologist makes from your file, not from our website. Many After Cancer customers are running She-Lajit Honey Sticks with oncologist sign-off; we make it easy to give them what they need to review.

Post-hysterectomy / surgical menopauseCompatible

Mosavi 2023 ran in this kind of population for FSFI improvement at 90 days. Whether your surgery left your ovaries in place or removed them changes the cyclical hormone environment but not the suitability of the formulation. Several women on the Surgical Survivor page are at this point.

Pregnancy / breastfeedingNot recommended

Shatavari has historical galactagogue uses, but the modern safety data on standardized extracts in pregnancy and lactation is insufficient to support a recommendation. Hold the formulation until you are not pregnant or nursing.

This page does not replace your prescriber. Bring the formulation to whoever holds your prescription pad. The full FAQ below has expanded answers for each of these rows.

WHO THIS WAS BUILT FOR

Find your cohort.

Perimenopause

Perimenopause

38–48

Still bleeding · Symptoms predate the bloodwork agreeing with you.

Menopause

Menopause

48–58

Twelve months past your last period · the year the symptom map redraws.

Late Bloomer

Late Bloomer

60+

Ten+ years past your last period · Pingali 2022 ran on women in your cohort.

Surgical Survivor

Surgical Survivor

Post-hysterectomy / oophorectomy

Mosavi 2023 RCT in your population.

After Cancer

After Cancer

Breast / endometrial history

Non-hormonal · Send the formulation to your oncologist.

COMPARED TO WHAT?

The fact-comparison table. Not the claim-comparison table.

Below is what each of these products contains and what its evidence base is. We do not compare what each product does. We compare what it contains.

Product Format Active ingredients Dose disclosed Evidence base Delivery route
She-Lajit Honey Sticks hersagain · the 4-Pathway Bloom Method™ Sublingual honey stick (8 g)

Shatavari (Asparagus racemosus) · Saffron (Crocus sativus) · Shilajit (Asphaltum punjabianum)

Yes — 80 mg / 2 mg / 300 mg printed on the label

Pingali Cureus 2024 (shatavari, RCT n=70, PMID 38725785) · Hausenblas 2013 (saffron neuropharmacology, 5-RCT meta, PMID 24299602) · Kashani 2022 (saffron, FSFI, PMID 36186931) · Pingali 2022 Phytomedicine (shilajit, RCT n=60, 48 wk, PMID 35933897) · Mosavi 2023 (shilajit, FSFI). Saffron is cited for mechanism, not as 2 mg dose validation.

Sublingual oral mucosal absorption; bypasses first-pass hepatic metabolism. (StatPearls NBK557852)
Bonafide Ristela Capsule (swallowed)

French maritime pine bark extract (Pinus pinaster) + L-arginine + L-citrulline + rose hip

Active doses partially disclosed on label; specifics per Bonafide product page

The clinical trials cited on the Ristela product page are the Lady Prelox trial series. Lady Prelox is a separate formulation; the trials were not conducted on the Ristela formulation. (Source: Bonafide product page citations, retrieved May 2026.)

Oral absorption (capsule swallowed; routed through hepatic portal system)
Olly Lovin' Libido Gummy

Ashwagandha (KSM-66) + Damiana + maca + cocoa

Per-gummy doses listed on label; ashwagandha 75 mg per gummy at Olly's reference serving (Olly product page, retrieved May 2026)

Ashwagandha (KSM-66) has trial literature in stress and reproductive-age populations; the specific menopausal-cohort RCT evidence on this formulation at this dose is not cited on the product page.

Oral absorption (chewed gummy; routed through hepatic portal system)
Womaness The Spark Capsule (swallowed)

Per Womaness product page at retrieval date; formulation contents subject to reformulation.

Partial — proprietary blend disclosure per product page (Womaness product page, retrieved May 2026)

No peer-reviewed RCT on this formulation cited on the product page at retrieval date.

Oral absorption (capsule swallowed)
HRT (general) Rx category Transdermal patch · oral tablet · injectable · vaginal estrogen

Estradiol · estradiol valerate · conjugated equine estrogens · progesterone (micronized) · medroxyprogesterone · testosterone (off-label for women in the US)

Per prescription

Decades of peer-reviewed clinical literature — WHI (2002), KEEPS, ELITE, NAMS 2022 position statement, and ongoing trials. The Nov 2025 FDA black-box removal updated the labeled risk language.

Varies by formulation (transdermal bypasses first-pass hepatic metabolism; oral tablets do not)

Competitor formulations and product pages change; we re-pull this table quarterly. We compare what each product contains and what its evidence base is — we do not compare claims about outcomes. (Outcome claims belong to the brand making them, and the FTC has been active in this category.)

Data retrieved May 2026

THE FULL WALL · FILTER BY COHORT

Twelve women. Twelve hometowns. The week each change showed up.

Filter by where you are — perimenopause, menopause, late bloomer, surgical, after cancer. Quotes are lightly trimmed for length, never edited for meaning.

Karen L.
Late BloomerJoints · Energy

Karen L.

64 · Portland, OR

postmenopausal 11 years

I am sixty-four, and three doctors told me it was too late to bother. I had stopped expecting to feel different. The joint pain is what I notice most — it is quieter now. I am just glad someone is finally building for my age group.

Week 6 joints · Week 10 energy

Sofia R.
PerimenopauseSleep · Mood

Sofia R.

41 · San Antonio, TX

I am forty-one. My GP ran the bloodwork, said it was normal, and asked if I had been under stress. I knew my body was telling the truth and the lab was not. Six weeks in, the 3 a.m. wake-ups stopped first — and that alone gave me my days back.

Week 3 sleep · Week 6 mood

Yvette B.
Surgical SurvivorLibido · Sleep

Yvette B.

52 · Asheville, NC

post-hysterectomy, surgical menopause

A hysterectomy four years ago put me into surgical menopause overnight. My surgeon said I would feel like a new person; the opposite happened. I sent the formulation to my doctor before I started. I will not call it a miracle — but the wanting to be close again came back, slowly, and I had stopped believing it would.

Week 4 sleep · Week 9 libido

Joy E.
MenopauseLibido · Joints

Joy E.

58 · Atlanta, GA

with HRT (estradiol patch + progesterone)

The estradiol patch handled my hot flashes, but the libido never came all the way back and my joints still ached. I added this alongside the patch — I checked with my prescriber first. It closed the gap the HRT was not touching. I want to want my husband again, and that is slowly coming back.

Week 6 joints · Week 10 libido

Carmen D.
Late BloomerEnergy · Mood

Carmen D.

71 · Spokane, WA

postmenopausal, never offered HRT

I am seventy-one. Of course I was never offered HRT — by the time I asked, every doctor said it was too late for me. I had made my peace with feeling like a shadow of myself. I did not expect much. What I got back was my mornings: I wake up and I am actually here. At my age that is everything.

Week 7 mood · Week 11 energy

Tessa N.
MenopauseFog · Energy

Tessa N.

49 · Seattle, WA

The brain fog was the part that scared me — I left a job I loved because I could not hold a thought. Less fog, more energy is the honest summary. It was somewhere around week eight that I read a whole page and actually remembered it.

Week 5 energy · Week 8 fog

Rachel B.
After CancerSleep · Mood

Rachel B.

47 · Columbus, OH

breast cancer history · on Tamoxifen · oncologist-approved

Breast cancer at forty-four, then Tamoxifen, and HRT was off the table for me. Most of the natural options are phytoestrogens at full dose, which my oncologist will not allow. I brought the ingredient list and the doses to her first. She read it and signed off. The night sweats settled and I am sleeping through again.

Week 4 sleep · Week 7 mood

Imani C.
PerimenopauseMood · Sleep

Imani C.

45 · Durham, NC

At forty-five I was spiraling — mood swings, night sweats, snapping at people I love. My doctor offered me an antidepressant and I knew that was not the whole story. This was the first thing that treated the actual signal instead of just flattening me. The spiraling settled around week five.

Week 3 sleep · Week 5 mood

Helen P.
Late BloomerJoints · Energy

Helen P.

67 · San Jose, CA

postmenopausal 14 years

I am sixty-seven and I had written off the joint aches and the flat, gray energy as just being my age now. I read the studies before I bought — the bone-density trial ran on women older than me. I am not going to overstate it. But I have more in the tank by mid-afternoon than I have had in years.

Week 6 energy · Week 12 joints

Robin A.
Surgical SurvivorSleep · Libido

Robin A.

55 · Boise, ID

post-oophorectomy, surgical menopause

They took my ovaries at fifty-one and I went from a normal life to feeling like an antique piece of barn equipment overnight. Robbed is the word I used. I checked the formulation with my doctor first. The sleep came back before anything else, and a few weeks later, so did some of the wanting. I had grieved that part of me.

Week 4 sleep · Week 10 libido

Marisol V.
PerimenopauseFog · Mood

Marisol V.

43 · Fresno, CA

Forty-three, still getting periods, and I was told I was too young for perimenopause and my bloodwork proved it. The bloodwork was a single snapshot of a storm. The fog was costing me at work. About a month in, it lifted enough that I trusted my own memory again.

Week 4 fog · Week 6 mood

Dottie W.
Late BloomerEnergy · Joints

Dottie W.

73 · Tulsa, OK

postmenopausal 20+ years

Seventy-three. My granddaughter found this for me because not one doctor in twenty years ever acted like a woman my age was worth helping. I keep my expectations low at this point. But I am steadier on the stairs and I am sleeping, and that has been a long time coming.

Week 8 joints · Week 10 energy

THE EVIDENCE STACK

From the RCTs the formula is built on.

V1 of this site is twelve months from launch. Our own outcomes survey is not yet large enough to publish here. So we show you the trials. Once we have at least 487 customer-cohort respondents at six months, this section replaces these RCT figures with our own. Until then: the underlying evidence base on which the formulation rests.

Significant quality-of-life gains

in the Pingali 2024 shatavari RCT — Utian Quality of Life scores rose markedly by day 60 versus placebo.

(n=70, peri- and postmenopausal women, standardized shatavari root extract 250 mg twice daily, RCT, Cureus 2024 — PMID 38725785.)

3–10× more absorbed

than the same botanicals swallowed in a capsule — sublingual delivery routes the actives past first-pass liver metabolism.

(Oral-mucosal sublingual absorption; StatPearls NBK557852.)

Dose-dependent BMD preservation

at the lumbar spine and femoral neck over 48 weeks in the Pingali 2022 shilajit RCT.

(n=60, postmenopausal women, 250–500 mg purified shilajit; Phytomedicine 2022.)

THE TRUST REPRISE

The parts that are usually hard, we made easy.

90-day money-back guarantee

Ninety days. Opened sticks count. No interrogation, no store-credit-only, no restocking fee. If it didn't work, we want the inventory back and your money to leave with you.

US shipping origin

Ships from Florida via our Miami fulfillment partner. Tracked. Domestic. No customs.

Real-human support

Phone, email, or chat — answered by a real human, Monday–Friday, 9am–6pm ET.

Bloom Handbook phone mockup

THE BLOOM HANDBOOK

Eighty pages. Free with your first order.

  • Chapter 1–3 — The Biology. What perimenopause is and is not. The 100+ symptom map honestly named (the ones that make the eight-symptom marketing lists, and the seven that get cut). What HRT does, what it does not, and what the post-WHI literature actually says.

  • Chapter 4–6 — The Choices. How to read a supplement label. How to verify a clinical trial citation in three minutes. How to evaluate any menopause product for the trust signals the Awakener checks in sixty seconds.

  • Chapter 7–10 — The Conversations. How to talk to a dismissive GP. How to bring the formulation to your oncologist or your prescribing physician. How to talk to your partner. How to talk to your daughter about what is coming for her.

EVERY QUESTION WE HEAR

The twenty-six questions, grouped by what they actually ask.

Mechanism

How is She-Lajit Honey Sticks actually different from another shatavari supplement on Amazon?

Three things. (1) Sublingual delivery — capsule shatavari is destroyed 70–90% by first-pass liver metabolism before it reaches your bloodstream. The same compound in a honey stick under the tongue is absorbed across oral mucosa and arrives at 3–10× the systemic concentration. (2) Four pathways, not one — shatavari is one of three molecular actives (alongside saffron and shilajit), each targeting a different system (receptor-level signal, brain neurochemistry, amplifying loops). A single-ingredient capsule covers one. (3) Standardized doses printed on the label — 80 mg standardized shatavari root extract, disclosed with its specification and delivered sublingually. (The Pingali Cureus 2024 RCT used a higher oral dose; we say so on Our Science rather than imply they match.) Most Amazon SKUs do not even disclose what their extract is standardized to.

Why are your doses lower than the doses in some of the cited trials?

Because of how sublingual absorption works. The published saffron trials (e.g., Hausenblas 2013 meta-analysis of 5 RCTs) used 30 mg/day oral saffron — the swallowed dose that survived first-pass hepatic metabolism. Sublingual delivery bypasses first-pass metabolism, so our 2 mg sublingual standardized extract is the dose we ship; we do not claim it is equivalent to the oral trial dose. The shatavari (80 mg) and shilajit (300 mg) doses match the published trial doses for those ingredients.

What does the "4-Pathway" name mean? Are they four equal pathways?

The name carries the four-count because all four matter — three molecular and one delivery. The diagram and the architecture table show the actual structure: shatavari at the receptor, saffron at the brain branch, shilajit at the amplifying loops, sublingual delivery as the route that makes the other three matter. If sublingual delivery were a fourth molecular pathway, that would be marketing math. It is a delivery channel, and naming it as one keeps the brand on the honest side of the mechanism story.

What happens if I stop taking it?

The pharmacology does not include the kind of dependency or withdrawal you see with SSRIs or hormone therapy. The compounds clear from your system over a few days. The benefits, measured in the trials, generally diminish over weeks rather than collapsing immediately — though the trial data on what happens after discontinuation is thinner than the data on what happens during the trial window. We do not have a "you must take this forever" claim to make. Customers who stop because they feel done usually feel the symptoms creep back over a month or two; some women cycle on and off depending on season or stress; both are reasonable.

Is the 4-Pathway Method patent-protected?

The individual ingredients are not patentable — shatavari, saffron, shilajit, and honey have been used in compound preparations for thousands of years. The 4-Pathway Bloom Method™ is a brand-named architecture and formulation that pairs (a) the specific four-pathway logic at (b) the specific doses in (c) the sublingual delivery vehicle. The architecture is trademarked. A competitor could copy the diagram form, but that would admit derivation and would not include our supply chain, our NAMS-physician review, or our trust architecture. We are not banking on patent enforcement; we are banking on getting the trust architecture right.

Safety

Can I take this with my HRT?

She-Lajit Honey Sticks are non-hormonal. We don’t make a categorical compatibility claim with any specific HRT regimen. Bring the full formulation and dose list to your prescriber before combining — and we’ll refund the order if your prescriber says it isn’t for you.

Can I take this with my SSRI / SNRI?

Saffron has documented serotonergic activity in published clinical trials. We don’t make a categorical compatibility claim with any specific SSRI or SNRI. Share the formulation with your prescriber and consider starting at one stick a day; stop and contact your prescriber if you notice any signs of serotonin syndrome (agitation, sweating, tremor, hyperthermia).

Is this safe if I am on blood thinners (warfarin, apixaban, rivaroxaban, dabigatran)?

We don’t have the trial data to make a categorical compatibility claim with anticoagulants. Bring the formulation to your hematologist or prescribing physician and let them decide. We will refund the order if your prescriber says it is not for you.

Is this safe if I have a breast cancer history or am on Tamoxifen?

Bring the formulation and dose list to your oncologist before starting. Several After Cancer customers are on the formulation with oncologist sign-off; the decision belongs to you and your oncologist together. Full ingredient list, doses, and the relevant published papers are linked from the After Cancer page. We will refund the order if your prescriber says it is not for you.

Is this safe after a hysterectomy?

Bring the formulation to your prescribing physician. Many post-hysterectomy customers use the formulation; whether your surgery left your ovaries in place or removed them changes the cyclical hormone environment but not the form-factor of the product. The Surgical Survivor page has the specific protocol notes.

Is this safe during pregnancy or breastfeeding?

Not recommended. Hold the formulation until you are no longer pregnant or nursing. The 4-Pathway Bloom Method is built for the perimenopausal, menopausal, and postmenopausal cohorts; pregnancy and lactation are out of scope of the trial evidence base.

Trust

Are the clinical trials cited on this product, or on a different formulation?

On the specific ingredients, in peri-, menopausal, postmenopausal, or reproductive-age women — with the trial dose stated, not blurred. (a) Shatavari — Pingali Cureus 2024 (PMID 38725785), n=70 peri- and postmenopausal women, standardized root extract, Utian Quality of Life improvement; the trial used a higher oral dose than our 80 mg sublingual, which we disclose. (b) Saffron — Hausenblas 2013 meta-analysis (PMID 24299602) and Kashani 2022 (PMID 36186931), both at ~30 mg oral; cited for the compound's neuropharmacology, not as 2 mg dose validation. (c) Shilajit 300 mg — Pingali 2022 Phytomedicine (PMID 35933897), n=60, 48 weeks, postmenopausal BMD, 250–500 mg/day (our 300 mg sits in range). Mosavi 2023, reproductive-age FSFI. Every primary trial is linked on Our Science. None of these are Lady Prelox.

Is the product third-party tested? For what?

Yes — every lot. Heavy metals (lead, arsenic, mercury, cadmium per USP <232>/<2232>), microbial limits per USP <2021>, and ingredient identity confirmed by HPLC for crocin/safranal (saffron), shatavarin saponins (shatavari), and fulvic acid percentage by titration plus DBP confirmation by HPLC (shilajit). Certificates of analysis are available on request — email care@hersagain.com with the lot number printed on your tube.

Is your supplement facts panel honest, or is there a proprietary blend?

Honest. There is no proprietary blend on this formulation. Every active ingredient lists its standardization spec and milligram dose on the label and on the supplement facts panel: Shatavari (Asparagus racemosus, root, standardized to ≥40% saponins) 80 mg · Saffron (Crocus sativus, stigma extract, standardized to ≥2% safranal) 2 mg · Shilajit (Asphaltum punjabianum, purified, ≥50% fulvic acid) 300 mg · Honey (Apis mellifera, US-sourced) 8 g. (One of the "leave-out" lines on the homepage is "no proprietary blends." We will not publish a formulation we will not commit to disclosing.)

Where is the product manufactured and shipped from?

Manufactured at a cGMP-certified, FDA-registered facility — third-party audited. Honey vehicle sourced from US apiaries in Florida. Order fulfillment from Florida; the return address on your shipping label is the Florida fulfillment partner. Tracked, domestic, no customs.

Commerce

How do I actually cancel my subscription?

Log into your account at hersagain.com/account → click Subscriptions → click Cancel subscription on the She-Lajit Honey Sticks line. Two taps. There is no phone queue, no chat retention department, no "are you sure?" pop-up that asks you the same question three times. The cancel screen is the screenshot above this FAQ. If for any reason the cancel flow does not work on your account, email care@hersagain.com from the address on the order and we will cancel manually within one business day.

What does the 90-day money-back guarantee actually cover?

Everything in the order, including opened sticks. Ninety days from delivery date (not ship date). Send back what you have not used — even if the box is opened, even if you used some of the sticks — and we refund the full order amount within five business days of receipt. The window is the same on subscription orders and on one-time orders. There is no restocking fee. There is no minimum-use period. If you reach week twelve and the formulation has not done what you hoped, you have three weeks left on the window.

Why is this $48/month when I can buy shatavari for $20 on Amazon?

Three places the cost goes. (1) Standardization — the Amazon shatavari capsule rarely discloses what the extract is standardized to; ours is standardized to ≥40% saponins and HPLC-confirmed at the lot level. The trial-grade input is more expensive than the bulk-spec input. (2) Sublingual delivery — the honey-stick matrix is a manufacturing step capsule supplements do not have. The honey itself is US-sourced rather than commodity. (3) The trust architecture you are paying for — real NAMS-certified physician review, real third-party testing, real 90-day open-product return window. The $20 Amazon SKU does not include the work of verification that this brand is built on. We are not trying to be the cheapest shatavari on the internet. We are trying to be the formulation you actually take.

Do you take HSA / FSA?

Yes, where eligible. Truemed integration is live at checkout — select "Pay with HSA/FSA" at checkout and Truemed routes the transaction. Whether your specific HSA/FSA plan covers nutritional supplements depends on the plan and on the medical-necessity letter Truemed generates. The Letter of Medical Necessity flow takes a few minutes; if it doesn't approve, default to credit card and email us — we can sometimes help.

How long does shipping take?

US domestic standard: 3–5 business days from order. Subscription orders ship within one business day of the scheduled charge. Tracking sent by email. International shipping is not currently offered. (We do not say "fast and free" because both of those are claims; we say the actual numbers.)

Identity

I'm 38 and my doctor said I'm too young for perimenopause. Is this for me?

Yes. The perimenopausal window opens for many women at 38 and for some women earlier — and the FSH/estradiol bloodwork your GP ran almost certainly came back "normal" because perimenopausal hormones are chaotic by definition and a single blood draw catches one moment in a storm. The Coslov 2024 paper put 63.3% of women 45–65 in the "not feeling like myself" category. The same paper documented that the perimenopausal symptoms predate the lab confirmation by years on average. Your symptoms are the more honest reading than the bloodwork. Pingali 2024 — our primary shatavari trial — ran on perimenopausal and menopausal women; the perimenopausal cohort showed the same direction of effect.

I'm 66 — is it too late for me?

No. Pingali 2022 Phytomedicine — our shilajit anchor study — ran for 48 weeks on 60 postmenopausal women and showed dose-dependent bone mineral density preservation at the lumbar spine and femoral neck. That was a postmenopausal trial. The 10-year rule that may have closed the HRT window for you applies to estradiol prescription, not to non-hormonal botanical mechanisms. The Late Bloomer page below was built for you, and the cohort filter on the testimonial wall above lets you see other 60+ customers. Karen L. (64, Portland), Carmen D. (71, Spokane) — both on the wall.

I had a hysterectomy. Is this for me?

Yes. Surgical menopause is its own version of the transition — sometimes more abrupt, often unresolved with the "six months to feel better" timeline a surgeon gave you. Mosavi 2023 ran an FSFI trial on shilajit in a reproductive-age population that is mechanistically relevant for the post-oophorectomy cohort. Whether your surgery removed your ovaries or left them is the variable that determines your cyclical hormone environment, but does not change the suitability of the formulation. The Surgical Survivor page below has the specific protocol notes, and Yvette B. (52, Asheville) is the four-years-post-op testimonial on the wall above.

I'm anti-hormone-treatment for personal reasons. Is this hormonal?

No. There is no estrogen, progesterone, testosterone, or DHEA in the formulation. There is no synthetic hormone, no bioidentical hormone, no hormone precursor. The shatavari fraction has SERM-like activity at estrogen receptors — meaning it interacts with the receptor site but is not estradiol — which is the mechanism worth knowing about if you are particularly conservative about phytoestrogenic activity at functional dose. At 80 mg standardized, it sits at a lower bioactive threshold than most phytoestrogen literature flags. This formulation is the build-for-the-woman-who-won't case. The "won't HRT" path on P-7 above was written for you.

I've tried Bonafide, Womaness, the shatavari capsule from Amazon, and the ashwagandha. None of them worked. Why should I expect this to be different?

Because the structural reasons those failed for you are addressable. Bonafide Ristela cites the Lady Prelox trial series — a separate formulation, not Ristela itself. Womaness and most of the OTC capsule shatavari options run through first-pass liver metabolism that destroys 70–90% of the dose before it reaches your bloodstream. The ashwagandha is a real ingredient with real stress-response evidence but does not cover the receptor-level signal, the brain-side neurochemistry, or the amplifying-loop pathways that menopausal symptoms actually run on. The 4-Pathway Bloom Method addresses all three of those pathways and uses sublingual delivery on the route question. If after ninety days the formulation does not move what you want it to move, the 90-day MBG covers the order in full — including opened sticks. We are not asking you to bet without the return window in place.